The prognostic value of D-dimer in lung cancer

Clinical Respiratory Journal

Volumn 9, Issue 3, 2015, Pages 305-313

  Inal, Tuba ^a   Anar, Ceyda ^a   Polat, Gülru ^a   Ünsal, Ipek ^a   Halilçolar, Hüseyin ^a  

^a Izmir Chest Diseases and Surgery Training Hospital   (Turkey)

Author keywords

D dimer; Lung cancer; Prognosis; Survival

Indexed keywords

D DIMER; HEMOGLOBIN; LACTATE DEHYDROGENASE; ANTINEOPLASTIC AGENT; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER STAGING; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; INTERNATIONAL NORMALIZED RATIO; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; SMALL CELL LUNG CANCER; THROMBOCYTE COUNT; TREATMENT RESPONSE; WORLD HEALTH ORGANIZATION; AGED; BLOOD; BLOOD CELL COUNT; BLOOD CLOTTING TEST; CARCINOMA; CASE CONTROL STUDY; LUNG TUMOR; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PREDICTIVE VALUE; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC AGENTS; BLOOD CELL COUNT; BLOOD COAGULATION TESTS; CARCINOMA; CASE-CONTROL STUDIES; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84936985766     PISSN: 17526981     EISSN: 1752699X     Source Type: Journal    
DOI: 10.1111/crj.12144     Document Type: Article

References (29)

1. Sculier JP, Chansky K, Crowley JJ, etal. The impact of additional prognostic factors on survival and their relationship with the anatomical extent of disease expressed by the 6th Edition of the TNM Classification of Malignant Tumors and the proposals for the 7th Edition. J Thorac Oncol. 2008;3: 457-466.
2. Berghmans T, Dusart M, Paesmans M, etal. Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer: a systematic review and meta-analysis by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project. J Thorac Oncol. 2008;3: 6-12.
3. Trousseau A. Phlegmasia alba dolens. In: Clinique Medicale de I'Hotel Dieu de Paris, Vol. 3, 2nd edn. Paris, Ballière, 1865: 654-712.
4. Falanga A, Rickles FR. Pathophysiology of the thrombophilic state in cancer patient. Semin Tromb Hemost. 1999;25: 173-182.
5. Kwaan HC, Keer HN. Fibrinolysis and cancer. Semin Tromb Hemost. 1990;16: 230-235.
6. Bick RL. Coagulation abnormalities in malignancy: a review. Semin Tromb Hemost. 1992;18: 596-602.
7. Gabazza EC, Taguchi O, Yamakami T, Machishi M, Ibata H, Suzuki S. Evaluating the prethrombotic state in lung cancer using molecular markers. Chest. 1993;103: 196-200.
8. Blomback B, Hessel B, Hogg D, Therkildsen L. A two-step fibrinogen-fibrin transition in blood coagulation. Nature. 1978;275: 501-505.
9. Buccheri G, Torchio P, Ferrigno D. Plasma levels of D-dimer in lung cancer. Cancer. 2003;97: 3044-3052.
10. Unsal E, Atalay F, Atikcan S, Yilmaz A. Prognostic significance of hemostatic parameters in patients with lung cancer. Resp Med. 2004;98: 93-98.
11. Altiay G, Ciftci A, Demir M, Kocak Z, Sut N, Tabakoglu E, Hatipoglu ON, Caglar T. High plasma D-dimer level is associated with decreased survival in patients with lung cancer. Clin Oncol. 2007;19: 494-498.
12. Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R. The IASLC Lung Cancer Staging Project: proposals fort he revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol. 2007;2: 706-714, 2007.
13. World Health Organization. International Histological Classification of Tumors. Berlin, Springer-Verlag, 1991.
14. Gouin-Thibault I, Samama MM. Laboratory diagnosis of the thrombophilic state in cancer patients. Semin Thromb Hemost. 1999;25: 167-172.
15. Guadagni F, Ferroni P, Basili S, etal. Correlation between tumor necrosis factor-alpha and D-dimer levels in non-small cell lung cancer patients. Lung Cancer. 2004;44(3): 303-310.
16. Taş F, Kiliç L, Serilmez M, Keskin S, Sen F, Duranyildiz D. Clinical and prognostic significance of coagülation assays in lung cancer. Respir Med. 2013;107: 451-457.
17. Kömürcüoğlu B, Ulusoy S, Gayaf M, Yalniz E, Özden E. Prognostic value of plasma D-dimer levels in lung carcinoma. J Thorac Oncol. 2007;2(8): S556.
18. Seitz R, Rappe N, Kraus M, Immel A, Wolf M, Maasberg M, Egbring R, Pfab R, Havemann K. Activation of coagulation and fibrinolysis in patients with lung cancer: relation to tumour stage and prognosis. Blood Coagul Fibrinolysis. 1993;4: 249-254.
19. Antoniou D, Pavlakou G, Stathopoulos GP, Karydis I, Chondrou E, Papageorgiou C, Dariotaki F, Chaimala D, Veslemes M. Predictive value of D-dimer plasma levels in response and progressive disease in patients with lung cancer. Lung Cancer. 2006;53: 205-210.
20. Luzatto N, Schoffer N. The trombotic state in cancer. Semin Oncol. 1990;17: 147-159.
21. Jemal A, Siege R, Ward E, Murray T, Xu J, Carol S, Thun MJ. Cancer Statistics, 2006. CA Cancer J Clin. 2006;56: 106-130.
22. Ursavaş A, Karadağ M, Uzaslan E, Yeşilkaya S, Coşkun F, Eğe E. Prognostic significance of plasma D-dimer levels in patients with lung cancer. Eur J Gen Med. 2010;7(2): 155-160.
23. Aydin N, Ulubaş B, Özcan M, Dalva K, Başer Y. Akciğer kanserlerinde koagülasyon/fibrinolizis; hücre tipi ve evrelerle ilişkisi. Solunum hastaliklari. 2000;11: 267-274.
24. Inal S, Taşçi C, Karadurmuş N, Kuzhan O, Balkan A, Özkan M, Bilgiç H, Özet A, Ekiz K. The association of D-dimer levels with other prognostic factors in patients with lung cancer. Turk J Med Sci. 2008;38(3): 209-217.
25. Hagedorn AB, Bowie EJW, Elveback LR, Owen CA. Coagulation abnormalities in patients with inoperable lung cancer. Mayo Clin Proc. 1974;49: 647-653.
26. Konda H, Shigekiyo T, Kojima A, Saritos N. Aquired factor VIII inhibitor in patient with adenocarcinoma of the lung. Jpn J Clin Oncol. 1992;122: 49-53.
27. Sheerwood P. Coagulation disorders in cancer, clinical and laboratory studies. Cancer. 1977;20: 1452.
28. Taguchi O, Gabazza E, Yasui H, Kobayashi T, Yoshida M, Kobayashi H. Prognostic significance of plasma D-dimer levels in patients with lung cancer. Thorax. 1997;52: 563-565.
29. Ay C, Dunkler D, Pirker R, Thaler J, Quehenberger P, Wagner O, Zielinski C, Pabinger I. High D-dimer levels are associated with poor prognosis in cancer patients. Haematologica. 2012;97(8): 1158-1164.